BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16953513)

  • 1. Diversity-oriented synthesis of pochonins and biological evaluation against a panel of kinases.
    Moulin E; Barluenga S; Totzke F; Winssinger N
    Chemistry; 2006 Nov; 12(34):8819-34. PubMed ID: 16953513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of a resorcylic acid lactone (RAL) library using fluorous-mixture synthesis and profile of its selectivity against a panel of kinases.
    Jogireddy R; Dakas PY; Valot G; Barluenga S; Winssinger N
    Chemistry; 2009 Nov; 15(43):11498-506. PubMed ID: 19821461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise synthesis of pochonin A, an HSP90 inhibitor.
    Moulin E; Barluenga S; Winssinger N
    Org Lett; 2005 Dec; 7(25):5637-9. PubMed ID: 16321010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical synthesis and biological evaluation of palmerolide A analogues.
    Nicolaou KC; Leung GY; Dethe DH; Guduru R; Sun YP; Lim CS; Chen DY
    J Am Chem Soc; 2008 Jul; 130(30):10019-23. PubMed ID: 18598030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of novel analogues of archazolid: a highly potent simplified V-ATPase inhibitor.
    Menche D; Hassfeld J; Sasse F; Huss M; Wieczorek H
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1732-5. PubMed ID: 17239591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity-oriented synthesis and preliminary biological screening of highly substituted five-membered lactones and lactams originating from an allyboration of aldehydes and imines.
    Elford TG; Ulaczyk-Lesanko A; De Pascale G; Wright GD; Hall DG
    J Comb Chem; 2009; 11(1):155-68. PubMed ID: 19072614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cis-enone resorcylic acid lactones (RALs) as irreversible protein kinase inhibitors.
    Wei L; Wu J; Li G; Shi N
    Curr Pharm Des; 2012; 18(9):1186-98. PubMed ID: 22316158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of resorcylic acid lactone analogues as covalent MNK1/2 kinase inhibitors by tuning the reactivity of an enamide Michael acceptor.
    Xu J; Chen A; Joy J; Xavier VJ; Ong EH; Hill J; Chai CL
    ChemMedChem; 2013 Sep; 8(9):1483-94. PubMed ID: 23929665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resorcylic acid lactones: naturally occurring potent and selective inhibitors of MEK.
    Zhao A; Lee SH; Mojena M; Jenkins RG; Patrick DR; Huber HE; Goetz MA; Hensens OD; Zink DL; Vilella D; Dombrowski AW; Lingham RB; Huang L
    J Antibiot (Tokyo); 1999 Dec; 52(12):1086-94. PubMed ID: 10695671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Hsp90 with synthetic macrolactones: synthesis and structural and biological evaluation of ring and conformational analogs of radicicol.
    Proisy N; Sharp SY; Boxall K; Connelly S; Roe SM; Prodromou C; Slawin AM; Pearl LH; Workman P; Moody CJ
    Chem Biol; 2006 Nov; 13(11):1203-15. PubMed ID: 17114002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An efficient synthesis of an exo-enone analogue of LL-Z1640-2 and evaluation of its protein kinase inhibitory activities.
    Wang SQ; Goh SS; Chai CLL; Chen A
    Org Biomol Chem; 2016 Jan; 14(2):639-645. PubMed ID: 26541872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry and biology of resorcylic acid lactones.
    Winssinger N; Barluenga S
    Chem Commun (Camb); 2007 Jan; (1):22-36. PubMed ID: 17279252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel selective human mitochondrial kinase inhibitors: design, synthesis and enzymatic activity.
    Ciliberti N; Manfredini S; Angusti A; Durini E; Solaroli N; Vertuani S; Buzzoni L; Bonache MC; Ben-Shalom E; Karlsson A; Saada A; Balzarini J
    Bioorg Med Chem; 2007 Apr; 15(8):3065-81. PubMed ID: 17324575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The migrastatin family: discovery of potent cell migration inhibitors by chemical synthesis.
    Gaul C; Njardarson JT; Shan D; Dorn DC; Wu KD; Tong WP; Huang XY; Moore MA; Danishefsky SJ
    J Am Chem Soc; 2004 Sep; 126(36):11326-37. PubMed ID: 15355116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total synthesis of a potent hybrid of the anticancer natural products dictyostatin and discodermolide.
    Paterson I; Naylor GJ; Wright AE
    Chem Commun (Camb); 2008 Oct; (38):4628-30. PubMed ID: 18815706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent syntheses of resorcylic acid lactones: L-783277, LL-Z1640-2, and hypothemycin.
    Dakas PY; Jogireddy R; Valot G; Barluenga S; Winssinger N
    Chemistry; 2009 Nov; 15(43):11490-7. PubMed ID: 19821460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gini coefficient: a new way to express selectivity of kinase inhibitors against a family of kinases.
    Graczyk PP
    J Med Chem; 2007 Nov; 50(23):5773-9. PubMed ID: 17948979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of potent cell migration inhibitors through total synthesis: lessons from structure-activity studies of (+)-migrastatin.
    Njardarson JT; Gaul C; Shan D; Huang XY; Danishefsky SJ
    J Am Chem Soc; 2004 Feb; 126(4):1038-40. PubMed ID: 14746469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total synthesis and biological evaluation of potent analogues of dictyostatin: modification of the C2-C6 dienoate region.
    Paterson I; Gardner NM; Guzmán E; Wright AE
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6268-72. PubMed ID: 18951787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel migrastatin and dorrigocin A analogues from D-glucal.
    Anquetin G; Rawe SL; McMahon K; Murphy EP; Murphy PV
    Chemistry; 2008; 14(5):1592-600. PubMed ID: 18038383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.